Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis

This study aimed to evaluate Atorvastatin (ATO)-associated hepatotoxicity using prescription sequence symmetry analysis (PSSA), based on a health insurance database of a Chinese population living in Jiangsu Province, China